Aytu BioScience Obtains CE Marking for Company's MiOXSYS(TM) System for Male Infertility

Regulatory Clearance Enables Commercialization in Europe and other Key Markets ENGLEWOOD, Colo., Jan. 12, 2016 -- (Healthcare Sales & Marketing Network) -- Aytu BioScience, Inc. (AYTU), a specialty healthcare company focused on commercializing treatmen... Biopharmaceuticals, Urology, RegulatoryAytu BioScience, MiOXSYS, ProstaScint, Primsol, trimethoprim
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news